Predictors of Response to Proton Pump Inhibitor Therapy among Children with Significant Esophageal Eosinophilia

Jason E. Dranove, Debra S. Horn, Miriam A. Davis, Kevin M. Kernek, Sandeep Gupta

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Objectives: To determine predictors of histological response to proton pump inhibitor (PPI) therapy among children with significant esophageal eosinophilia (SEE), defined as ≥15 eosinophils per high powered field (eos/hpf) on esophageal mucosal biopsy (EMB). Study design: Response to PPI therapy among children with SEE treated with PPI who underwent repeat EMB was studied retrospectively. Response was defined as <5 eos/hpf on repeat EMB. Characteristics of responders and nonresponders were analyzed. Results: Of 326 patients (ages 1 through 18 years) diagnosed with SEE over a 7-year period, 43 (mean age, 8.5 years; 67% males) met inclusion criteria. After PPI therapy, 17 patients (40%) were responders. There were no significant differences in demographics, presenting symptoms, endoscopic, or histological findings between responders and nonresponders. Among patients with 15 to 20 eos/hpf on EMB, 50% were responders; among patients with >20 eos/hpf on EMB, 29% were responders. Seven of 17 (41%) patients with abnormal pH monitoring and 5 of 11 (45%) patients with normal monitoring were responders. Conclusions: Forty percent of patients with SEE demonstrated histological response to PPI therapy. None of the clinical characteristics evaluated predicted response, and response was not dependent on results of pH study. The role of PPI therapy in treating SEE warrants further prospective investigation.

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalJournal of Pediatrics
Volume154
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Proton Pump Inhibitors
Eosinophilia
Biopsy
Eosinophils
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Predictors of Response to Proton Pump Inhibitor Therapy among Children with Significant Esophageal Eosinophilia. / Dranove, Jason E.; Horn, Debra S.; Davis, Miriam A.; Kernek, Kevin M.; Gupta, Sandeep.

In: Journal of Pediatrics, Vol. 154, No. 1, 01.2009, p. 96-100.

Research output: Contribution to journalArticle

Dranove, Jason E. ; Horn, Debra S. ; Davis, Miriam A. ; Kernek, Kevin M. ; Gupta, Sandeep. / Predictors of Response to Proton Pump Inhibitor Therapy among Children with Significant Esophageal Eosinophilia. In: Journal of Pediatrics. 2009 ; Vol. 154, No. 1. pp. 96-100.
@article{4f27334d82944a4fa280d7e3b3ac5662,
title = "Predictors of Response to Proton Pump Inhibitor Therapy among Children with Significant Esophageal Eosinophilia",
abstract = "Objectives: To determine predictors of histological response to proton pump inhibitor (PPI) therapy among children with significant esophageal eosinophilia (SEE), defined as ≥15 eosinophils per high powered field (eos/hpf) on esophageal mucosal biopsy (EMB). Study design: Response to PPI therapy among children with SEE treated with PPI who underwent repeat EMB was studied retrospectively. Response was defined as <5 eos/hpf on repeat EMB. Characteristics of responders and nonresponders were analyzed. Results: Of 326 patients (ages 1 through 18 years) diagnosed with SEE over a 7-year period, 43 (mean age, 8.5 years; 67{\%} males) met inclusion criteria. After PPI therapy, 17 patients (40{\%}) were responders. There were no significant differences in demographics, presenting symptoms, endoscopic, or histological findings between responders and nonresponders. Among patients with 15 to 20 eos/hpf on EMB, 50{\%} were responders; among patients with >20 eos/hpf on EMB, 29{\%} were responders. Seven of 17 (41{\%}) patients with abnormal pH monitoring and 5 of 11 (45{\%}) patients with normal monitoring were responders. Conclusions: Forty percent of patients with SEE demonstrated histological response to PPI therapy. None of the clinical characteristics evaluated predicted response, and response was not dependent on results of pH study. The role of PPI therapy in treating SEE warrants further prospective investigation.",
author = "Dranove, {Jason E.} and Horn, {Debra S.} and Davis, {Miriam A.} and Kernek, {Kevin M.} and Sandeep Gupta",
year = "2009",
month = "1",
doi = "10.1016/j.jpeds.2008.07.042",
language = "English",
volume = "154",
pages = "96--100",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Predictors of Response to Proton Pump Inhibitor Therapy among Children with Significant Esophageal Eosinophilia

AU - Dranove, Jason E.

AU - Horn, Debra S.

AU - Davis, Miriam A.

AU - Kernek, Kevin M.

AU - Gupta, Sandeep

PY - 2009/1

Y1 - 2009/1

N2 - Objectives: To determine predictors of histological response to proton pump inhibitor (PPI) therapy among children with significant esophageal eosinophilia (SEE), defined as ≥15 eosinophils per high powered field (eos/hpf) on esophageal mucosal biopsy (EMB). Study design: Response to PPI therapy among children with SEE treated with PPI who underwent repeat EMB was studied retrospectively. Response was defined as <5 eos/hpf on repeat EMB. Characteristics of responders and nonresponders were analyzed. Results: Of 326 patients (ages 1 through 18 years) diagnosed with SEE over a 7-year period, 43 (mean age, 8.5 years; 67% males) met inclusion criteria. After PPI therapy, 17 patients (40%) were responders. There were no significant differences in demographics, presenting symptoms, endoscopic, or histological findings between responders and nonresponders. Among patients with 15 to 20 eos/hpf on EMB, 50% were responders; among patients with >20 eos/hpf on EMB, 29% were responders. Seven of 17 (41%) patients with abnormal pH monitoring and 5 of 11 (45%) patients with normal monitoring were responders. Conclusions: Forty percent of patients with SEE demonstrated histological response to PPI therapy. None of the clinical characteristics evaluated predicted response, and response was not dependent on results of pH study. The role of PPI therapy in treating SEE warrants further prospective investigation.

AB - Objectives: To determine predictors of histological response to proton pump inhibitor (PPI) therapy among children with significant esophageal eosinophilia (SEE), defined as ≥15 eosinophils per high powered field (eos/hpf) on esophageal mucosal biopsy (EMB). Study design: Response to PPI therapy among children with SEE treated with PPI who underwent repeat EMB was studied retrospectively. Response was defined as <5 eos/hpf on repeat EMB. Characteristics of responders and nonresponders were analyzed. Results: Of 326 patients (ages 1 through 18 years) diagnosed with SEE over a 7-year period, 43 (mean age, 8.5 years; 67% males) met inclusion criteria. After PPI therapy, 17 patients (40%) were responders. There were no significant differences in demographics, presenting symptoms, endoscopic, or histological findings between responders and nonresponders. Among patients with 15 to 20 eos/hpf on EMB, 50% were responders; among patients with >20 eos/hpf on EMB, 29% were responders. Seven of 17 (41%) patients with abnormal pH monitoring and 5 of 11 (45%) patients with normal monitoring were responders. Conclusions: Forty percent of patients with SEE demonstrated histological response to PPI therapy. None of the clinical characteristics evaluated predicted response, and response was not dependent on results of pH study. The role of PPI therapy in treating SEE warrants further prospective investigation.

UR - http://www.scopus.com/inward/record.url?scp=57249094325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57249094325&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2008.07.042

DO - 10.1016/j.jpeds.2008.07.042

M3 - Article

C2 - 18783791

AN - SCOPUS:57249094325

VL - 154

SP - 96

EP - 100

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -